Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹59.90
Market cap
₹129.2 Cr
Revenue (annual)
₹23.73 Cr
Net profit (annual)
₹-16.93 Cr
P/E (TTM)
-9.2×Sector 47.4×
Promoter holding
72.74%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:07 IST BSE
Legal & Regulatory

Krebs Biochemicals & Industries Legal & Regulatory

Krebs Biochemicals and Industries Ltd filed its shareholding pattern for June 2026, detailing promoter, institutional and other holdings. 20,400 promoter shares are in court dispute and remain undematerialised.